These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29100374)

  • 1. Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.
    Santagata S; Napolitano M; D'Alterio C; Desicato S; Maro SD; Marinelli L; Fragale A; Buoncervello M; Persico F; Gabriele L; Novellino E; Longo N; Pignata S; Perdonà S; Scala S
    Oncotarget; 2017 Sep; 8(44):77110-77120. PubMed ID: 29100374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment.
    Santagata S; Rea G; Castaldo D; Napolitano M; Capiluongo A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Di Maro S; Tatangelo F; Albino V; Guarino R; Cutolo C; Izzo F; Scala S
    Hepatol Int; 2024 Apr; 18(2):568-581. PubMed ID: 37142825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.
    Santagata S; Rea G; Bello AM; Capiluongo A; Napolitano M; Desicato S; Fragale A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Persico F; Di Napoli M; Di Maro S; Feroce F; Azzaro R; Gabriele L; Longo N; Pignata S; Perdonà S; Scala S
    Br J Cancer; 2024 Jun; 130(12):2016-2026. PubMed ID: 38704478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.
    Braza F; Dugast E; Panov I; Paul C; Vogt K; Pallier A; Chesneau M; Baron D; Guerif P; Lei H; Laplaud DA; Volk HD; Degauque N; Giral M; Soulillou JP; Sawitzki B; Brouard S
    J Am Soc Nephrol; 2015 Aug; 26(8):1795-805. PubMed ID: 25556168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of apoptosis of CD4+ CD25+ regulatory T cells on proliferation as well as secretion of effector T cells and interventional activity of Xuebijing injection in septic rats].
    Ai YH; Yao YM; Dai XG
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(1):58-61. PubMed ID: 19484954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients.
    Alvarez Salazar EK; Cortés-Hernández A; Alemán-Muench GR; Alberú J; Rodríguez-Aguilera JR; Recillas-Targa F; Chagoya de Sánchez V; Cuevas E; Mancilla-Urrea E; Pérez García M; Mondragón-Ramírez G; Vilatobá M; Bostock I; Hernández-Méndez E; De Rungs D; García-Zepeda EA; Soldevila G
    Front Immunol; 2017; 8():219. PubMed ID: 28316600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma may evade the immune system by converting CD4+Foxp3- T cells into CD4+CD25+Foxp3+ regulatory T cells: Role of tumor COX-2-derived PGE2.
    Li J; Feng G; Liu J; Rong R; Luo F; Guo L; Zhu T; Wang G; Chu Y
    Mol Med Rep; 2010; 3(6):959-63. PubMed ID: 21472340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
    Bouvy AP; Klepper M; Kho MM; Boer K; Betjes MG; Weimar W; Baan CC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1587-97. PubMed ID: 24771499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Sharma S; Khosla R; David P; Rastogi A; Vyas A; Singh D; Bhardwaj A; Sahney A; Maiwall R; Sarin SK; Trehanpati N
    Front Immunol; 2015; 6():49. PubMed ID: 25767469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.
    Desar IM; Jacobs JH; Hulsbergen-vandeKaa CA; Oyen WJ; Mulders PF; van der Graaf WT; Adema GJ; van Herpen CM; de Vries IJ
    Int J Cancer; 2011 Jul; 129(2):507-12. PubMed ID: 20839259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.
    Yokokawa J; Cereda V; Remondo C; Gulley JL; Arlen PM; Schlom J; Tsang KY
    Clin Cancer Res; 2008 Feb; 14(4):1032-40. PubMed ID: 18281535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
    Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
    Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
    Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
    Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.